Asian Stock: Sinopharm Group

Company: Sinopharm Group Company Limited

Bloomberg ticker: 1099 HK

Market cap: US$8,554m

Background: Sinopharm Group Company Limited is the largest pharmaceutical distributor in China by revenue. It researches and develops, manufactures and markets medicines, ranging from traditional Chinese medicines to prescription and over-the-counter healthcare products and medical devices. The company serves hospitals, clinics, and drug stores.
 

World Class Benchmarking of Sinopharm Group

(Click on image to enlarge)

  • Profitable Growth rank of 8 was same compared to the prior period’s 8th rank
  • This is below average performance compared to 380 large Health Care companies worldwide
  • Profitability rank of 8 was worse than its Growth rank of 5
  • Profitability rank of 8 was the same compared to the prior period’s 8th rank
  • This is below average performance compared to peers
  • Growth rank of 5 was up compared to the prior period’s 6th rank
  • This is average performance compared to peers

More By This Author:

European Stock: Prada SpA
European Stock: Burberry Group
European Stock: Kering SA

Disclaimer: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and ...

more
How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.
Or Sign in with